Evidence map›Paper›PMID 28781602›Full record

ArticleNutrition & metabolism2017

eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet.

Woo-Gyun Choi, Jaeseok Han, Ji-Hyeon Kim, Mi-Jeong Kim, Jae-Woo Park, Benbo Song, Hee-Jeong Cha, Hye-Seon Choi, Hun-Taeg Chung, In-Kyu Lee and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Translation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3.International journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  13. Article
  14. Fructose and hepatic insulin resistance.Critical reviews in clinical laboratory sciences · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Inhibition of eIF2BioMed research international · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Woo-Gyun Choi *School of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
Jaeseok Han *Soonchunhyang Institute of Med-bio Science (SIMS), Soonchunhyang University, Cheonan-si, Choongchungnam-do, 31151 Republic of Korea.
Ji-Hyeon Kim *School of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
Mi-Jeong KimSchool of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
Jae-Woo ParkSchool of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
Benbo SongNGM Biopharmaceuticals, Inc., 333 Oyster Point Blvd, South San Francisco, CA 94080 USA.
Hee-Jeong ChaDepartment of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, 44043 Republic of Korea.
Hye-Seon ChoiSchool of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
Hun-Taeg ChungSchool of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.
In-Kyu LeeDepartment of Internal Medicine and Biochemistry and Cell Biology, Kyungpook National University School of Medicine, Daegu, 41944 Republic of Korea.
Tae-Sik ParkDepartment of Life Science, Gachon University, Seongnam, Republic of Korea.
Maria HatzoglouDepartment of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH 44106 USA.
Hueng-Sik ChoiSchool of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Hyun Ju YooBiomedical Research Center, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, 05505 Republic of Korea.
Randal J KaufmanSoonchunhyang Institute of Med-bio Science (SIMS), Soonchunhyang University, Cheonan-si, Choongchungnam-do, 31151 Republic of Korea.
Sung Hoon BackSchool of Biological Sciences, University of Ulsan, Ulsan, 44610 Republic of Korea.ORCID 0000-0001-8029-1298
Ulsan College · KRChonnam National University · KRSoonchunhyang University · KRAsan Medical Center · KRGachon University · KRKyungpook National University · KRNGM Biopharmaceuticals (United States) · USUniversity School · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Translational Control by Osmotically Active SolutesR37DK060596 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI HATZOGLOU, MARIA · 2011 to 2020
$5.3M
Role of the Unfolded Protein Response in Beta CellR37DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2007 to 2016
$4.9M
Modifiers of Proinsulin Influence T2D SusceptibilityR24DK110973 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ARVAN, PETER, ITKIN-ANSARI, PAMELA ROSE · 2016 to 2019
$4.1M
ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinomaR01CA198103 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUFMAN, RANDAL J. · 2016 to 2020
$3.4M
Homeostatic Role of IRE1a-XBP1-PDI1 in Hepatic Lipid MetabolismR01DK103185 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUFMAN, RANDAL J. · 2015 to 2019
$2.9M
Unfolded Protein Response in Glucose HomeostasisR01DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2003 to 2006
$1.2M
NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA198103NIDDK NIH HHS R01 DK042394NIDDK NIH HHS R01 DK103185NIDDK NIH HHS R24 DK110973NIDDK NIH HHS R37 DK042394NIDDK NIH HHS R37 DK060596
6 · The paper itself

Abstract

backgroundDietary fructose can rapidly cause fatty liver in animals through de novo lipogenesis (DNL) and contribute to the development and severity of nonalcoholic fatty liver disease (NAFLD). In response to diverse cellular insults including endoplasmic reticulum (ER) and oxidative stress, phosphorylation of the eukaryotic translation initiation factor 2 alpha subunit (eIF2α) attenuates general translation initiation, allowing cells to conserve resources and initiate adaptive gene expression to restore homeostasis. The present study aimed to investigate the role of eIF2α phosphorylation in protecting against NAFLD induced by high fructose ingestion in a hepatocyte-specific eIF2α-phosphorylation-deficient mouse model.

methodsHepatocyte-specific non-phosphorylatable (S51A) eIF2α knock-in (

resultsProlonged fructose feeding to mice caused dysregulation of the unfolded protein response (UPR) sensor activation and UPR gene expression, and then led to decreased expression of several ROS defense genes including glutathione biogenesis genes. Nonetheless, these changes were not sufficient to induce the death of eIF2α phosphorylation-sufficient hepatocytes. However, there was a substantial increase in hepatocyte death and liver fibrosis in fructose-fed middle-aged mice deficient in hepatocyte-specific eIF2α phosphorylation because of diminished antioxidant capacity due to reduced expression of antioxidant enzymes (GPX1 and HO-1) and lower NADPH and glutathione levels, as well as a possible increase in ROS-induced damage from infiltrating NOX2-expressing leukocytes; all this led to a vicious cycle of hepatocyte death and leukocyte infiltration.

conclusionOur findings suggest that eIF2α phosphorylation maintains NADPH and GSH levels and controls the expression of ROS-defense genes, thereby protecting hepatocytes from oxidative stresses induced by fructose metabolism.

Indexed as

AgingAntioxidant enzymeseIF2α phosphorylationFibrosisGlutathioneHigh fructose dietNADPHNonalcoholic fatty liver diseaseOxidative stress

Identifiers

PMID28781602
PMCPMC5537942
OpenAlexW2739763500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.